Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-03-05 @ 12:49 AM
Study NCT ID:
NCT02681861
Status:
COMPLETED
Last Update Posted:
2017-01-10
First Post:
2016-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
Sponsor:
Astellas Pharma Europe B.V.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
6294-CL-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None